Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A device for phototesting patients before PUVA therapy

B L Diffey1, D A De Berker, P J Saunders

  • 1Regional Medical Physics Department, Dryburn Hospital, Durham, U.K.

The British Journal of Dermatology
|December 1, 1993
PubMed
Summary

A new phototesting device simplifies minimal phototoxic dose determination before PUVA therapy. This robust, easy-to-use tool allows for rapid assessment, improving patient treatment planning.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photodiagnostic services in the UK and Republic of Ireland: a British Photodermatology Group Workshop Report.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

A theoretical and experimental study of the temporal reduction in UV protection provided by a facial day cream.

International journal of cosmetic science·2018
Same author

Erythropoietic protoporphyria and solar urticaria.

The British journal of dermatology·2018
Same author

Localized inflammatory reactions at sites of subcutaneous methotrexate injections during treatment with ultraviolet B.

The British journal of dermatology·2018
Same author

An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema.

The British journal of dermatology·2017
Same author

The influence of HIV infection on the age dependence of squamous cell carcinoma of the skin in South Africa.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2017

Area of Science:

  • Dermatology
  • Photomedicine
  • Medical Device Development

Background:

  • Photochemotherapy, specifically PUVA (psoralen plus ultraviolet A) therapy, requires precise determination of the minimal phototoxic dose (MPD).
  • Accurate MPD determination is crucial for initiating effective and safe PUVA treatment protocols.
  • Existing methods for MPD determination can be time-consuming or complex.

Purpose of the Study:

  • To describe and validate a novel, simplified device for rapid phototesting.
  • To enable easy determination of the minimal phototoxic dose (MPD) prior to initiating PUVA therapy.
  • To assess the reliability and usability of the new phototesting device.

Main Methods:

  • A phototesting template with four apertures of varying radiation attenuation (1, 2, 4, 8 relative intensities) was developed.

Related Experiment Videos

  • The device was validated against a standard method using variable exposure times in 11 subjects.
  • Minimal phototoxic dose was assessed visually, and erythema was measured using reflectance spectrophotometry.

    • Main Results:

    • The novel device allowed for MPD determination in a single exposure with varying intensities.
    • Visual assessment of MPD using the new device yielded identical results compared to the standard method.
    • Reflectance measurements confirmed no systematic differences between the novel device and the standard method.

    Conclusions:

    • The described phototesting device offers a rapid, easy, and robust method for MPD determination.
    • Its simple design, lacking moving parts and power requirements, facilitates wider clinical application.
    • This device can significantly improve the efficiency and accessibility of pre-PUVA therapy patient assessment.